Evelyn Wong: CM8HW Reports Final Overall Survival Results With Nivolumab Plus Ipilimumab
Evelyn Wong/LinkedIn

Evelyn Wong: CM8HW Reports Final Overall Survival Results With Nivolumab Plus Ipilimumab

Evelyn Wong, Consultant, Division of Medical Oncology at National Cancer Centre Singapore, shared on X:

“Final OS results CM8HW:

  • 1L nivoipi vs chemo: HR 0.37; 5yr OS 77% vs 46%
  • Nivoipi vs nivo across all: HR 0.61; 5yr OS 74% vs 62%. 1L OS nivo–ipi vs nivo missed the prespecified sig threshold (P<0.0058):
  • HR 0.66; P=0.0432
  • 5yr OS 77% vs 66%.”

Evelyn Wong: CM8HW Reports Final Overall Survival Results With Nivolumab Plus Ipilimumab

You can also read:

20 Posts Not to Miss from ESMO Congress 2026: Day 2

Evelyn Wong: CM8HW Reports Final Overall Survival Results With Nivolumab Plus Ipilimumab